Abstract-In the present study, a series of N-substituted sulfonamides have been synthesized. The reaction of benzene sulfonyl chloride (1) with O-anisidine (2) yielded N-(2-methoxyphenyl) benzenesulfonamide (3), which on bromination with bromine in the presence of acetic acid gave N-(4,5-dibromo-2-methoxyphenyl)benzenesulfonamide (6). The two products (3) and (6) 
Introduction
Sulfonamides containing group -SO2NH-is a present in many pharmacologically active compounds [1] . Sulfonamides are considered as an important group of drugs which are used widely as antimicrobial, high ceiling diuretics, ant thyroid and anti-inflammatory agents [2] . The mechanism through which sulfonamides perform its function is to inhibit the conversion of p-amino benzoic acid, thus creating hurdle in utilization of p-amino benzoic acid for bacteria in folic acid synthesis which leads to formation of purine and DNA [3] . Many infectious diseases caused by Gram-negative and Gram-positive bacteria are also cured by widely used sulfonamides [4] . These compounds also find their wide application as antitumor, anticancer and anti-viral agent because they have been reported to inhibit cancer cell growth and to cease tumor invasion [2] . Although excessive use of other antibiotics has ceased the usefulness of different sulfonamides, even then these clinically active compounds have therapeutically important place [4] . Sulfonamides are also ruling as most widely used second veterinary medicine [3] . Some derivatives of sulfonamides are extensively used for gastrointestinal and urinary tract infections because of their ease of administration and non-interaction with defense mechanism of host [5] . All these findings encouraged us to explore the synthesis of different N-substituted sulfonamides derived from o-anisidine with improved and different biological activity. In lipoxygenase type-1 (LOX, EC 1.13.11.12), the iron is present in the divalent state and is oxidized to the catalytically active Fe 3+ by the reaction product 15-hydroperoxy-eicosatetraenoic acid (15-HPETE) and leukotrienes from arachidonic acid as a substrate, and 13-hydroperoxy-octadecadienoic acid (13-HPODE) from linoleic acid as a substrate [6, 7] . Leukotrienes are important biologically active mediators in a variety of inflammatory events. It has been found that these LOX products play a key role in variety of disorders such as bronchial asthma, inflammation [8, 9] . In this work, we report various N-substituted derivatives of o-anisidine. First, a parent sulfonamide N-(2-methoxyphenyl) benzenesulfonamide (3) was prepared by reacting benzene sulfonyl chloride with o-anisidine in basic media at room temperature in excellent yield. Further bromination of 3 yielded N-(4, 5-dibromo-2-methoxyphenyl)benzene sulfonamide (6) . Simple stirring gave the desired compounds that were further processed to obtain different N-substituted sulfonamides. Literature survey revealed that minor modification in the structure of compound can result in qualitative as well as quantitative changes in the activity, which prompted us to carry out the synthesis of various sulfonamide derivatives of o-anisidine and to study their structure-International Journal of Chemical Research ISSN: 0975-3699 & E-ISSN: 0975-9131, Vol. 3, Issue 3, 2011 activity relationship; these were screened against AChE, BChE and lipoxygenase (LOX) and were found active against LOX.
Materials and Methods
General TLC was performed on pre-coated silica gel G-25-UV254 plates. Detection was carried out at 254 nm, and by ceric sulphate reagent. Purity was checked on TLC with different solvent systems using ethyl acetate and nhexane giving single spot. The IR spectra were recorded in KBr on a Jasco-320-A spectrophotometer (wave number in cm -1 ). 1 H NMR spectra were recorded in CDCl3 on a Bruker spectrometers operating at 400 MHz. Chemical shifts are given in ppm. Mass spectra (EIMS) were measured on Finnigan MAT-112 instrument. EI-MS were recorded in were recorded on a JMS-HX-110 spectrometer, with a data system. The melting points were recorded on a Griffin & George melting point apparatus by open capillary tube and were uncorrected.
Procedure for the synthesis of sulfonamide in aqueous medium
A mixture of benzenesulfonyl chloride (10.0 mmol; 1.3 mL) and O-anisidine (10.0 mmol; 2.6 mL) was suspended in 50 mL water. The pH of the suspension was adjusted and was maintained at 10.0 by adding basic aqueous solution of a Na2CO3 at room temperature. The reaction mixture was stirred and monitored with TLC for the completion of reaction. Then concentrated HCl was added slowly to adjust the pH to 2.0. The precipitates were collected by filtration, washed with distilled water and dried to afford the title compound 3. The product was dissolved in ethanol and recrystallized by slow evaporation of the solvent, to generate off white crystalline solid of N-(2-methoxyphenyl) benzenesulfonamide. Yield 94%.
Bromination
of N-(2-methoxyphenyl) benzenesulfonamide (3) 2g of compound 3 was dissolved in 15 mL of glacial acetic acid. The bromine liquid (2 mL) was added gradually in the reaction mixture for the bromination of 3. The reaction mixture was stirred at room temperature for at least 2 hours and the completion of reaction was monitored by TLC. The product was filtered, washed with distilled water and dried to afford light orange precipitates of N-(4, 5-dibromo-2-methoxyphenyl)benzenesulfonamide (6) . Yield 92%.
General procedure for the synthesis of N-alkyl substituted sulfonamides in DMF The calculated amount of 3 or 6 (0.1 mmol) was taken in a round bottomed flask (50 mL), then dimethyl formamide DMF (10 mL) was added to dissolve it followed by the addition of sodium hydride (0.1 mmol) to the mixture. The mixture was stirred for 30 minutes at room temperature and then slowly added the alkyl halide/acyl halide to the mixture and the solution was further stirred for three hours. The progress of reaction was monitored via TLC till single spot. The product was precipitated by adding water. It was filtered, washed with water and crystallized from aqueous methanol.
Acetylcholinesterase assay
The AChE inhibition activity was performed according to the method with slight modifications. Total volume of the reaction mixture was 100 µL. It contained 60 µL Na2HPO4 buffer with concentration of 50 mM and pH 7.7. Ten µL test compound (0.5 mM well -1 ) was added, followed by the addition of 10 µL (0.005 unit well -1 ) enzyme. The contents were mixed and pre-read at 405 nm. Then contents were pre-incubated for 10 min at 37ºC. The reaction was initiated by the addition of 10 µL of 0.5 mM well -1 substrate (acetylthiocholine iodide), followed by the addition of 10 µL DTNB (0.5 mM well -1 ). After 15 min of incubation at 37ºC, absorbance was measured at 405 nm. Synergy HT (BioTek, USA) 96-well plate reader was used in all experiments. All experiments were carried out with their respective controls in triplicate. Eserine (0.5 mM well -1 ) was used as a positive control. The percent inhibition was calculated by the help of following equation [10] .
Control

Butyrylcholinesterase assay
The BChE inhibition activity was performed according to the method with slight modifications. Total volume of the reaction mixture was 100 µL containing 60 µL, Na2HPO4 buffer, 50 mM and pH 7.7. Ten µL test compound 0.5 mM well -1 , followed by the addition of 10 µL (0.5 unit well -1 ) BChE. The contents were mixed and pre-read at 405 nm and then pre-incubated for 10 mins at 37ºC. The reaction was initiated by the addition of 10 µL of 0.5 mM well -1 substrate (butyrylthiocholine bromide) followed by the addition of 10 µL DTNB, 0.5 mM well -1 . After 15 min of incubation at 37ºC, absorbance was measured at 405 nm. Synergy HT (BioTek, USA) 96-well plate reader was used in all experiments. All experiments were carried out with their respective controls in triplicate. Eserine (0.5 mM well -1 ) was used as positive control. The percent inhibition was calculated by the help of following equation [10] .
Control IC50 values (concentration at which there is 50% enzyme inhibition) of compounds were calculated using EZ-Fit Enzyme kinetics software (Perella Scientific Inc. Amherst, USA).
Lipoxygenase assay
Lipoxygenase activity was assayed according to the reported method [11] [12] [13] but with slight modifications. A total volume of 200 µL assay mixture contained 150 µL Bioinfo Publications sodium phosphate buffer (100 mM, pH 8.0), 10 µL test compound and 15µL purified lipoxygenase enzyme (Sigma, USA). The contents were mixed and pre-read at 234 nm and preincubated for 10 minutes at 25°C. The reaction was initiated by addition of 25 µL substrate solution. The change in absorbance was observed after 6 min at 234 nm. Synergy HT (BioTek, USA) 96-well plate reader was used in all experiments. All reactions were performed in triplicates. The positive and negative controls were included in the assay. Quercetin (0.5 mM well -1 ) was used as a positive control. The percentage inhibition was calculated by formula given below.
Inhibition (%) = Control -Test × 100 
Results and Discussion
Compound 3 was synthesized as off white crystalline solid. The molecular formula C13H12NO3S was established by HR-MS showing molecular ion peak at m/z 263.3164 (calcd. for C13H12NO3S, 263.3131). The IR spectrum revealed the presence of methoxy group (1258 cm -1 ), a sulfonyl group (1341 cm -1 ) and -NH-group (3430 cm -1 ) in the molecule. The EIMS gave distinct peak at m/z 199 after the removal of sulfony group and further fragment ion peak was observed at m/z 232 which showed the presence of methoxy groups in the molecule. In the aromatic region of the 1 H-NMR spectrum of 3, signals appeared at δ 7.66 (dd, J = 7.2, 1.2 Hz, 2H, H-2′, H-6′), 7.53 (br t, J = 7.2 Hz, 1H, H-4′) and 7.51 (br t, J = 7.2 Hz, 2H, H-3′, H-5′). Due to downfield shift, these protons were assigned to monosubstituted ring bearing sulfonyl group and the signals appearing at δ 7.42 (ddd, J = 1.6, 7. In the aliphatic region, a singlet was appeared at δ 3.32 corresponding to the methoxy group present in the molecule. On the basis of these evidences the structure Bioinfo Publications of 3 was assigned as N-(2-methoxyphenyl)benzenesulfonamide. Similarly on the basis of structural evidences from IR, EIMS, and 1 H-NMR, the structures of other derivatives were elucidated as described in experimental section. The screening of these sulfonamide derivatives against acetyl cholinesterase, butyryl cholinesterase and lipoxygenase enzymes revealed that they were inactive against acetyl cholinesterase (AchE) but exhibited good inhibitory potential against lipoxygenase as it was evident from their IC50 values (Table 1) . Among these, Nbutyl-N-(4,5-dibromo-2-methoxyphenyl)benzenesulfonamide (6d) and N-pentyl-N-(4,5-dibromo-2-methoxy phenyl)benzenesulfonamide (6e) were found to be the good inhibitors having IC50 value of 90.81 ± 0.91and 78.65 ± 0.85 µmoles respectively, relative to baicalein, a reference standard with IC50 value of 22.4 ± 1.3 µmoles, probably due to the substitution of butyl and pentyl group respectively in these molecules. The screening against butyryl cholinesterase enzyme revealed that only two compounds, namely, N-isopropyl-N-(2-methoxy phenyl)benzenesulfonamide (5c) and N-benzyl-N-(2-methoxyphenyl)benzenesulfonamide (5h) exhibited inhibitory potential, however all other compounds were inactive. 
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